Results 271 to 280 of about 297,289 (305)
Some of the next articles are maybe not open access.
Annales de biologie clinique, 2014
LDL-cholesterol value is one of the criteria used by the Haute autorité de santé (HAS) in the management of patients in primary and secondary prevention with the aim to reduce cardiovascular mortality. In this respect, the recommendations have been established based on target to achieve LDL-cholesterol.
Arnaud, Reignier +6 more
openaire +2 more sources
LDL-cholesterol value is one of the criteria used by the Haute autorité de santé (HAS) in the management of patients in primary and secondary prevention with the aim to reduce cardiovascular mortality. In this respect, the recommendations have been established based on target to achieve LDL-cholesterol.
Arnaud, Reignier +6 more
openaire +2 more sources
Statins and LDL‐cholesterol lowering: an overview
Current Medical Research and Opinion, 2005Statins have become a cornerstone of treatment for dyslipidaemia primarily due to their marked lowering of low-density lipoprotein cholesterol (LDL-C). Studies show that statin treatment typically reduces relative risk of cardiovascular disease by 24-37%, regardless of age, sex, prior history of coronary heart disease (CHD), or other co-morbid ...
openaire +2 more sources
LDL cholesterol and troglitazone therapy
Diabetes Care, 1998B V, Howard, W J, Howard
openaire +2 more sources
LDL-cholesterol, HDL-cholesterol or triglycerides—which is the culprit?
Diabetes Research and Clinical Practice, 2003Dyslipidaemia in patients with type 2 diabetes commonly consists of elevated triglyceride levels; normal or slightly elevated low-density lipoprotein (LDL)-cholesterol levels with a preponderance of small, dense LDL particles; and low high-density lipoprotein (HDL)-cholesterol levels with a preponderance of small, dense HDL.
openaire +2 more sources
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
European Heart Journal, 2021Renato Quispe +2 more
exaly